August 16, 2026 11:54 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
After SC rebuke, BCI chief apologises to NALSAR students over enrolment freeze row | Independence Day: PM Modi’s big youth pitch— AI training, free coaching amid exam row and job concerns | ‘Shakti Ki Saptadhara’: Modi reveals 7 pillars to power India’s next leap in his I-Day speech from Red Fort | West Bengal STF arrests 3 more suspected Pakistani spies in Cooch Behar | Bengal man arrested in Bengaluru over terror links, Afghanistan travel plan | Ajit Doval breaks silence on Operation Sindoor in Discovery’s explosive new docuseries | Rahul Gandhi's 'mock hug' taunt sparks row; Centre stresses 'mutual respect' with Italy | Delhi on high alert: Bomb threat to High Court, airport and multiple locations ahead of I-Day | ‘Who are they to interfere?’: CJI Surya Kant slams Bar Council of India over NALSAR students’ enrolment row | 'Shows how low Congress has sunk': BJP slams Rahul Gandhi over Modi foreign policy jibe

FIR against Snapdeal CEO for selling prescription drugs online

| | May 01, 2015, at 11:58 pm
Mumbai, May 1 (IBNS) Maharashtra's Food and Drugs Administration (FDA) has ordered that a First Information Report (FIR) be filed against Kunal Bahl, the CEO of e-commerce giant Snapdeal.com, for the sale of prescription drugs online.
FDA commissioner Harshadeep Kamble said on Friday said the FIR has been ordered against  Bahl and directors of the company.
 
The FDA said it had received information about the alleged sale of a cough syrup, and certain tablets, both prescription drugs that can be sold only when prescribed by medical practitioner.
 
The FDA had issued a notice to the company asking it to delist the drugs and also furnish details of the drugs it offered for sale on the portal Snapdeal.com.
 
In a statement on Friday, Snapdeal said they are assisting in the probe and have delisted the products.
 
"In this matter, we are assisting the FDA team in this investigation and we will continue to do so. We have already delisted the products and said sellers and also stopped payment, in addition to providing all information to the FDA team as required by them," the statement said.
 
The FDA has said it is also checking to see if other e-retailers have sold drugs online.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.